Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Lifecore Biomedical, Inc. - Common Stock
(NQ:
LFCR
)
5.830
-0.130 (-2.18%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
212,957
Open
5.810
Bid (Size)
5.750 (1)
Ask (Size)
6.510 (1)
Prev. Close
5.960
Today's Range
5.805 - 5.960
52wk Range
4.500 - 11.46
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 22, 2024
From
Lifecore Biomedical, Inc.
Via
GlobeNewswire
Lifecore Biomedical Completes Incremental Liquidity Initiatives
May 16, 2024
Recent Initiatives Provide Approximately $8 Million of Non-Dilutive, Incremental Liquidity through Various Amendments with Lenders
From
Lifecore Biomedical, Inc.
Via
GlobeNewswire
Performance
YTD
-8.62%
-8.62%
1 Month
-7.31%
-7.31%
3 Month
-27.40%
-27.40%
6 Month
-21.74%
-21.74%
1 Year
-27.58%
-27.58%
More News
Read More
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC
May 14, 2024
Via
TheNewswire.com
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC
May 14, 2024
Via
NewMediaWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
ROSEN, A LEADING LAW FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC
May 10, 2024
Via
NewMediaWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
ROSEN, A LEADING LAW FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC
May 10, 2024
Via
TheNewswire.com
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC
May 08, 2024
Via
NewMediaWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC
May 08, 2024
Via
TheNewswire.com
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
ROSEN, A LEADING LAW FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation – LFCR, LNDC
May 07, 2024
From
The Rosen Law Firm PA
Via
GlobeNewswire
ROSEN, A LEADING NATIONAL FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC
May 03, 2024
Via
NewMediaWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
ROSEN, A LEADING NATIONAL FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC
May 03, 2024
Via
TheNewswire.com
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
ROSEN, A TOP RANKED LAW FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation – LFCR, LNDC
April 30, 2024
From
The Rosen Law Firm PA
Via
GlobeNewswire
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC
April 29, 2024
Via
NewMediaWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC
April 29, 2024
Via
TheNewswire.com
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC
April 26, 2024
Via
NewMediaWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC
April 26, 2024
Via
TheNewswire.com
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
ROSEN, A LEADING AND TOP RANKED LAW FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation – LFCR, LNDC
April 25, 2024
From
The Rosen Law Firm PA
Via
GlobeNewswire
NATIONALLY RANKED ROSEN LAW FIRM Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC
April 23, 2024
Via
NewMediaWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
NATIONALLY RANKED ROSEN LAW FIRM Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC
April 23, 2024
Via
TheNewswire.com
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
ROSEN, A RANKED AND LEADING FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC
April 21, 2024
Via
NewMediaWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
ROSEN, A RANKED AND LEADING FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDC
April 21, 2024
Via
TheNewswire.com
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation – LFCR, LNDC
April 20, 2024
From
The Rosen Law Firm PA
Via
GlobeNewswire
Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report
April 19, 2024
From
Lifecore Biomedical, Inc.
Via
GlobeNewswire
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation – LFCR, LNDC
April 15, 2024
From
The Rosen Law Firm PA
Via
GlobeNewswire
ROSEN, A TOP RANKED LAW FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation – LFCR, LNDC
April 11, 2024
From
The Rosen Law Firm, P.A.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.